Galera Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Galera Therapeutics

14/08/2023 14:32

* Galera Therapeutics Inc  GRTX.OQ  reported a quarterly
adjusted
loss of 48 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 38 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Galera Therapeutics Inc's reported EPS for the quarter was
a
loss of 48 cents​.
    * The mean earnings estimate of analysts had fallen by
about 14.4%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Galera Therapeutics Inc shares had fallen by 89.7% this
quarter and lost 78.4% so far this year.
    * The company reported a quarterly loss of $20.71 million.
    * Wall Street's median 12-month price target for Galera
Therapeutics Inc is $0.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.38          -0.48          Missed
 Mar. 31 2023      -0.38          -0.50          Missed
 Dec. 31 2022      -0.54          -0.58          Missed
 Sep. 30 2022      -0.52          -0.60          Missed